相关实验视频

Updated: Jun 16, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

毒素:一种潜在的新免疫检查点在癌症通过胰腺癌分析的癌症

Shengliang Qiu¹, Weiye Lin², Zhengyang Zhou³

¹The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 54 Youdian Road, Hangzhou, 310006, China.

Discover oncology

|August 16, 2024

概括

胸细胞选择相关的HMG-BOX (TOX) 与各种癌症有关,影响T细胞耗尽和免疫细胞透. TOX可能成为癌症治疗的新生物标志物和治疗点.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学遗传学是一个

背景情况:

胸细胞选择相关的HMG-BOX (TOX) 是一种与瘤发育和T细胞枯竭相关的转录因子.
它在癌症中的作用需要使用全面的基因组数据进行进一步的研究.

研究的目的:

使用癌症基因组图谱 (TCGA) 数据调查TOX在胰腺癌发育和进展中的作用.
探索TOX表达,免疫微环境和患者预后之间的关系.

主要方法:

从TCGA,GTEx,HPA,GeneCards和STRING数据库中分析了RNA-seq,遗传改变和TOX的蛋白质水平.
通过使用TCGA生存数据和通过TIMER 2.0和CIBERSORT的免疫细胞透来评估预后意义.
通过免疫组织化学和CCK-8测定验证的结果.

主要成果:

在大多数TCGA癌症类型中观察到差异性TOX表达,与患者预后相关.
毒素水平与免疫相关途径,免疫细胞透和免疫检查点有显著的关联.
免疫组织化学证实了TOX表达差异,细胞活力测试显示TOX影响癌细胞增殖.

结论:

TOX是一种潜在的泛癌生物标志物,参与调节瘤免疫微环境.
向TOX可能为癌症治疗提供新的治疗策略.

关键词:

癌症预后癌症预后免疫检查站检查站免疫治疗是一种免疫疗法.多种omics技术的技术.托克斯 (Tox) 是一种毒素.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.